Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$376K Sell
1,794
-1,418
-44% -$356K 0.02% 668
2025
Q4
$913K Sell
3,212
-30
-0.9% -$9.38K 0.05% 334
2025
Q3
$1M Buy
3,242
+1,859
+134% +$582K 0.05% 255
2025
Q2
$435K Buy
1,383
+164
+13% +$47.3K 0.03% 425
2025
Q1
$320K Buy
1,219
+105
+9% +$28.4K 0.03% 402
2024
Q4
$291K Buy
1,114
+59
+6% +$14.9K 0.03% 406
2024
Q3
$246K Sell
1,055
-27
-2% -$5.54K 0.02% 400
2024
Q2
$218K Buy
+1,082
New +$195K 0.02% 413
2024
Q1
Sell
-2,652
Closed -$575K 496
2023
Q4
$575K Buy
+2,652
New +$455K 0.02% 373

Other funds holding PODD

Syon Capital's PODD Position: Q1 2026 in Review

Syon Capital reduced its Insulet (PODD) stake by 44% in Q1 2026, selling an estimated $356K and leaving 1,794 shares worth $376K. The position accounts for 0.02% of the portfolio, ranked #668.

Syon Capital first reported a position in PODD in Q4 2023 and has held it in 9 quarters since. The position peaked at $1M in Q3 2025. 784 funds tracked by Wall St. Rank hold PODD as of Q1 2026.

  • Syon Capital held 1,794 shares of Insulet worth $376K as of Q1 2026.
  • Syon Capital sold 1,418 Insulet shares in Q1 2026, an estimated $356K.
  • Insulet made up 0.02% of Syon Capital's portfolio in Q1 2026, its #668 holding.
  • Syon Capital first reported a position in Insulet in Q4 2023 and has held it in 9 quarters since.
  • Syon Capital's Insulet position peaked at $1M in Q3 2025.
  • 784 funds tracked by Wall St. Rank held Insulet as of Q1 2026.

Based on Syon Capital's 13F filing for Q1 2026, filed 13 May 2026.